Skip to main content

Table 2 Laboratory results during certoparin therapy in all study patients (n = 62)

From: Antifactor Xa activity in critically ill patients receiving antithrombotic prophylaxis with standard dosages of certoparin: a prospective, clinical study

 

Baseline

12 h

24 h

P-value

Prothrombin (%)

87 ± 14

88 ± 13

90 ± 14

0.240

aPTT (sec)

39 ± 9

38 ± 7

38 ± 7

0.183

Antithrombin (%)

73 ± 17

75 ± 17

77 ± 17

0.006a

Fibrinogen (mg/dl)

497 ± 198

529 ± 201

551 ± 211

<0.001a

Hemoglobin (g/dl)

10.2 ± 1.3

10.3 ± 1.3

10 ± 1.1

0.221

Platelets (g/l)

189 ± 103

183 ± 96

199 ± 119

0.055

Serum creatinine (mg/dl)

1.35 ± 0.85

-

1.41 ± 0.95

0.536

Serum urea (mg/dl)

67 ± 40

-

72 ± 42

0.072

  1. a, significant time effect.
  2. PT, Prothrombin Time; aPTT, activated Partial Thromboplastin Time; AT, Antithrombin; -, not measured,
  3. Data are given as mean values ± SD.